Inhibikase Therapeutics Conducts Observational Study on Patients with History of PML

Inhibikase Therapeutics Conducts Observational Study on Patients with History of PML
Inhibikase Therapeutics, Inc. has just launched an observational clinical study of patients with a history of Progressive Multifocal Leukoencephalopathy (PML), an uncommon but highly fatal infection of the brain that has been linked as an adverse effect of some medications for autoimmune diseases, such as multiple sclerosis, blood and lymph cancers, and inflammatory bowel diseases (IBD).

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *